Ecotera Health develops AI-driven diagnostic platforms that measure microplastics and nanoplastics in human biofluids, translating environmental exposure data into health insights. The biomedical startup is building smartphone-based and laboratory-integrated systems for samples such as urine, blood, and saliva, with its EcoExposure platform aimed at decentralized monitoring and population-scale research. Its work connects environmental sensing with biological assays and potential interventions for exposure-associated disease.